Sarepta director receives 16,875 RSUs grant

Barry Richard reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Barry Richard reported acquisition or exercise transactions in this Form 4 filing.

Sarepta Therapeutics, Inc. reported that director Barry Richard received a grant of 16,875 shares of Common Stock as restricted stock units (RSUs) at a price of $0.00 per share. These RSUs will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders that is at least 50 weeks after the prior year's annual meeting.

Following this grant, Richard directly holds 2,983,542 shares of Sarepta common stock. He also has indirect ownership of 10,000 shares through an LLC and 240,000 shares through a trust, as reported in the filing.

Insider Trade Summary

Grant/Award: 16,875 shares

Grant/Award 3 txns

Insider Barry Richard

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	16,875	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,983,542 shares (Direct); Common Stock — 240,000 shares (Indirect, By Trust); Common Stock — 10,000 shares (Indirect, By LLC)

Footnotes (1)

1. F1. The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.

Key Figures

RSU grant size: 16,875 shares Grant price: $0.00 per share Direct holdings after grant: 2,983,542 shares +2 more

5 metrics

RSU grant size 16,875 shares Restricted stock units granted to Barry Richard

Grant price $0.00 per share Price per share for RSU award

Direct holdings after grant 2,983,542 shares Barry Richard direct Sarepta common stock position

Indirect LLC holdings 10,000 shares Indirect ownership by LLC

Indirect trust holdings 240,000 shares Indirect ownership by trust

Key Terms

restricted stock units ("RSUs"), vest, annual meeting of stockholders

3 terms

restricted stock units ("RSUs") financial

"The Reporting Person was granted restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest financial

"The RSUs will vest on earlier of the one-year anniversary of the date of grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"the next annual meeting of stockholders which is at least 50 weeks after"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sarepta Therapeutics (SRPT) report for Barry Richard?

Sarepta Therapeutics reported that director Barry Richard received 16,875 restricted stock units of common stock. The Form 4 shows this as a compensation-related grant, not an open-market purchase or sale, with the RSUs converting into shares upon vesting.

How many Sarepta (SRPT) shares were granted to Barry Richard in this Form 4?

Barry Richard was granted 16,875 restricted stock units, each representing one share of Sarepta common stock. The grant price is listed as $0.00 per share, indicating a stock-based compensation award rather than a cash purchase in the open market.

What are the vesting terms of Barry Richard’s Sarepta (SRPT) RSU award?

The RSUs granted to Barry Richard will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders. That stockholder meeting must occur at least 50 weeks after the preceding year's annual meeting, according to the footnote.

How many Sarepta (SRPT) shares does Barry Richard hold after this RSU grant?

After the RSU grant, Barry Richard directly owns 2,983,542 shares of Sarepta common stock. The Form 4 also reports additional indirect holdings through an LLC and a trust, reflecting separate ownership structures beyond his direct position.

What indirect Sarepta (SRPT) holdings are reported for Barry Richard?

The filing shows 10,000 shares of Sarepta common stock held indirectly through an LLC and 240,000 shares held through a trust. These positions are classified as indirect ownership, separate from Barry Richard’s directly held 2,983,542-share stake.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 08:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barry Richard

(Last) (First) (Middle)

215 FIRST STREET

SUITE 415

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sarepta Therapeutics, Inc. [ SRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		16,875	A	(1)	2,983,542	D
Common Stock								240,000	I	By Trust
Common Stock								10,000	I	By LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.

	/s/ Cristin Rothfuss, as Attorney-in-Fact for Richard Barry	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)